Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Results of Operations and Financial Condition
Item2.02 Results of Operations and Financial Condition
On April 12, 2017, Rennova Health, Inc. (the Company) issued a
press release announcing its results of operations for the twelve
monthsended December 31, 2016. A copy of the press release is
furnished as Exhibit99.1 to this report.
The information furnished to this Item2.02, including
Exhibit99.1, shall not be deemed filed for purposes of Section18
of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise subject to the liabilities under that section
and shall not be deemed to be incorporated by reference into any
filing of the Company under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such filing.
Item9.01 Financial Statements and Exhibits
(d)Exhibits
The following exhibit is furnished as part of this report:
| Exhibit No. | Description | |
| 99.1 | Press Release of Rennova Health, Inc., dated April 12, 2017. |
About Rennova Health, Inc. (NASDAQ:RNVA)
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc. Rennova Health, Inc. (NASDAQ:RNVA) Recent Trading Information
Rennova Health, Inc. (NASDAQ:RNVA) closed its last trading session down -0.09 at 1.23 with 362,595 shares trading hands.
